Structure, biochip, device and method for separating red blood cells
By using the connecting hole structure of the magnetic bead cavity and the filter membrane in the structure of the isolated red blood cell, the filter membrane is blocked and ruptured, and efficient plasma filtration is achieved, solving the problem of large area and high cost of the filter membrane, and improving detection reliability and applicability.
Patent Information
- Application Number
- CN202310569855.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-19
- Publication Date
- 2024-11-22
AI Technical Summary
When the filter membrane filtration method is large, it is easy to cause blockage of whole blood samples, causing rupture of red blood cells, and the filter membrane is too large, costly, and the stability and efficiency of existing magnetic bead technology are not high.
A structure to isolate red blood cells is designed, using the connecting hole structure of the magnetic bead cavity and the filter membrane. Magnetic beads that adsorb antibodies to red blood cells are placed in the magnetic bead cavity. Magnetic beads are adsorbed through magnets to prevent red blood cells from entering the filter membrane, avoiding blockage, and The plasma filtration is achieved by slowly down-pressing the plunger, reducing the area of the filter membrane.
It effectively avoids rupture and hemolysis of red blood cells, reduces the use area of the filter membrane to one-twenty-fifth of the original, reduces the cost, has a wide range of application, simple process, and reliable results.
Smart Images

Figure CN118995393A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biological instruments, and in particular to a structure, a biological chip, a device and a method for separating red blood cells. Background Art
[0002] Currently, in the in vitro diagnostic (IVD) testing industry, many test items cannot be directly tested with whole blood. The red blood cells in the whole blood need to be separated and the plasma sample is retained for testing. The current traditional methods include centrifugation and membrane filtration suitable for biochips.
[0003] Centrifugation uses the density difference between red blood cells and plasma to sink red blood cells suspended in plasma to the bottom through high-speed rotation, so that red blood cells and plasma are physically separated. The advantages of this method are: a large amount of whole blood can be separated at one time, and no additional consumables are required each time it is used; the disadvantages are: it requires the addition of centrifuge equipment, cannot be implanted in detection instruments or biochips, and increases the operation time and steps of medical staff.
[0004] The membrane filtration method uses the physical size of red blood cells and plasma to design corresponding pores on the membrane so that plasma can pass through and red blood cells are intercepted, thereby obtaining the required plasma. The advantages of this method are: it can be implanted in a biochip that does not require much plasma samples. When testing, only whole blood needs to be added, and then it can be placed in the detection instrument for full-process testing. Only the result needs to be waited for, and the operation is simple. The disadvantages are: the volume of whole blood that can be filtered per unit area of the membrane is small. When the amount of whole blood to be filtered is large, a larger membrane area needs to be added, which will undoubtedly increase the volume of the biochip and reduce the applicability of the product; this type of filter membrane can only use imported filter membranes at present, and the cost is high. Chinese utility model patent CN210079266U discloses a structure for lateral separation of red blood cells. The structure for separating red blood cells laterally includes a substrate, a first assembly cavity and a second assembly cavity arranged in the substrate, and a sample loading port and a collection cavity extending downward from the top surface of the substrate; the first assembly cavity is used to place a first filter element, the second assembly cavity is used to place a second filter element, and the sample loading port, the first assembly cavity, the second assembly cavity and the collection cavity are connected in series; the second filter element is arranged vertically to form a lateral filter element. However, when using the membrane filtration method, in the case of a large volume of specimen, it is easy for the whole blood sample to block the blood filter membrane, block the liquid driving force, and prevent the plasma from flowing in the preset manner, and even cause the red blood cells to rupture and hemolyze, affecting the test results; the blood filter membrane needs to be strictly sealed when used to prevent red blood cells from leaking from the side, and the bonding process is complicated.
[0005] Immunomagnetic bead technology (IMB) couples coated antibodies on the surface of magnetic beads to react with antigens and antibodies, binds to the surface of antigens to form immune complexes, and separates antigen-antibody-magnetic bead immune complexes under strong magnetic action to achieve antigen screening or remove labeled antigens. Plasma is obtained by quickly separating red blood cells using immunomagnetic bead technology and applied to immunological testing, which can better serve clinical diagnosis. In the existing patent technology, Chinese patent application number CN200710305363.6 discloses a method for separating red blood cells from whole blood using magnetic microspheres coated with lectins or anti-red blood cell antibodies. Chinese patent application number CN200810244503.8 discloses a method for preparing a freeze-dried whole blood or suspended red blood cell separation reagent based on CN200710305363.6. Although the stability of the separation reagent is improved, the separation time still requires 10 minutes. In these two public patents, the particle size of the magnetic microparticles used is 10-20 μm. In these two patents, the coating of antibodies and magnetic particles is physical adsorption rather than chemical coupling, and the reagent stability and work efficiency are not high. Chinese patent application number CN202010128026.X discloses a method for producing immunomagnetic beads with a diameter of 1-4 μm using anti-erythrocyte antibodies or lectins chemically coupled. Chinese patent application number CN202010490280.4 discloses an immunomagnetic bead for separating red blood cells and its preparation method and application, which relates to the field of immunomagnetic bead preparation technology. The preparation method of the immunomagnetic beads comprises: step S1, activating the magnetic beads with an activator, wherein the weight ratio of the magnetic beads to the activator is 1:0.1-5; the activation time is 5-30 minutes; step S2, adding anti-erythrocyte antibody to the activated product obtained in step S1, and performing ultrasonic treatment; step S3, adding a blocking agent to the product obtained in step S2 for blocking, and performing strong magnetic separation to obtain immunomagnetic beads for separating red blood cells; the step S3 also comprises: washing the obtained immunomagnetic beads for separating red blood cells, adding them to a preservation solution, dispersing them uniformly, dividing them into small portions according to the required amount, and performing vacuum drying, wherein the preservation solution is 50mM tris(hydroxymethyl)aminomethane and 0.5wt% bovine serum albumin, and the pH value of the preservation solution is 7.8. The activator comprises at least one of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, N-hydroxysuccinimide, glutaraldehyde, periodate, and chloramine-T. In step S3, the blocking agent is selected from at least one of 1-5wt% bovine serum albumin solution, 0.1-5wt% casein solution and 10-50mM glycine. The magnetic beads are polystyrene microspheres coated with ferroferric oxide. The particle size of the magnetic beads is 1-5μm. In step S2, the mass ratio of the anti-erythrocyte antibody to the magnetic beads is: 1:10-1000.This patent uses a vacuum drying method to prepare freeze-dried immunomagnetic beads. The red blood cell adsorption and separation time of 500uL whole blood sample is 2 minutes. However, this method directly adds the whole blood sample to the vial containing the freeze-dried reagent. The volume of the whole blood sample that can be separated is limited and cannot be flexibly adjusted.
[0006] Chinese patent application number CN202210965075.8 discloses an immunomagnetic bead freeze-dried microsphere for separating red blood cells, and a preparation method, application and blood processing device thereof, wherein the immunomagnetic bead freeze-dried microsphere comprises magnetic beads and anti-red blood cell antibodies coupled to the magnetic beads, wherein the magnetic beads are ferroferric oxide magnetic beads wrapped with polystyrene, and the coupling agent is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; the preparation method of the immunomagnetic bead freeze-dried microsphere comprises the following steps: S1, adding anti-red blood cell antibodies and coupling agents to a magnetic bead solution for coupling reaction, wherein the mass ratio of the anti-red blood cell antibodies to the magnetic beads is 1:20-95; S2, adding a blocking agent to the product obtained by S1 for blocking, strong magnetic separation, adding a buffer solution, and mixing evenly to obtain an immunomagnetic bead mixed solution; S3, subjecting the immunomagnetic bead mixed solution obtained by S2 to liquid nitrogen freeze-vacuum drying to obtain immunomagnetic bead freeze-dried microspheres, wherein the diameter of the immunomagnetic bead freeze-dried microspheres is 0.1-0.4 μm. Summary of the invention
[0007] In view of the shortcomings of the prior art, the present invention aims to provide a structure for separating red blood cells to solve the problem that the whole blood sample is prone to block the filter membrane when the pressure volume is large, resulting in red blood cell rupture and hemolysis.
[0008] In order to solve the above technical problems, the technical solution of the present invention is as follows:
[0009] A structure for separating red blood cells comprises a substrate, wherein the substrate is provided with a whole blood sample injection port and a first chamber, wherein the whole blood sample injection port is connected to the first chamber, wherein a plunger is provided in the first chamber, and further comprises a magnetic bead chamber and a second chamber, wherein a plurality of magnetic beads are provided in the magnetic bead chamber, wherein antibodies for adsorbing red blood cells are provided on the magnetic beads, wherein the bottom of the first chamber is connected to the second chamber via a connecting hole, and wherein a filter membrane is provided in the second chamber.
[0010] The whole blood sample is added to the magnetic bead chamber to combine the red blood cells and the magnetic beads. The magnetic beads are paramagnetic magnetic beads used in conventional reagent detection. Antibodies with red blood cell adsorption are coupled to the magnetic beads. The red blood cells in the whole blood sample are adsorbed on the magnetic beads. The mixed whole blood sample is added to the first chamber from the whole blood sample port. The existence of the connecting hole makes the whole blood sample stay in the first chamber, preventing the whole blood sample from directly entering the second chamber and avoiding the red blood cells from being adsorbed on the filter membrane. The magnetic beads are adsorbed on the side away from the filter membrane by a magnet, and the plunger is driven to slowly press down. The plasma in the whole blood sample enters the second chamber through the connecting hole and contacts the filter membrane. A small amount of red blood cells and impurities such as white blood cells in the whole blood are blocked on the filter membrane. After the plasma in the whole blood sample passes through the filter membrane, the filtration of the whole blood sample is completed. Since the red blood cells in the whole blood sample are adsorbed on the magnetic beads and sucked, it is avoided that the red blood cells block the filter membrane, block the liquid driving force, and prevent the plasma from flowing in the preset manner, and even cause the red blood cells to rupture and hemolyze, and at the same time greatly reduce the use area of the filter membrane.
[0011] Furthermore, the aperture of the communicating hole is 0.3-1 mm. Thus, when the whole blood sample is added to the first chamber, the communicating hole can block the whole blood sample from entering the second chamber, thereby preventing the red blood cells from being adsorbed on the filter membrane.
[0012] Furthermore, the particle size of the magnetic beads is 0.1 μm-5 μm.
[0013] In a preferred embodiment of the present invention, the particle size of the magnetic beads is 0.1 μm-1 μm.
[0014] Furthermore, the substrate is provided with an A surface and a B surface facing each other; a boss is provided at one end of the second chamber facing the B surface, and the filter membrane is fixedly connected to the second chamber via the boss; a cover sheet is provided on the B surface of the substrate, and the second chamber is covered by the cover sheet to form a sealed chamber. In this way, the boss can limit the filter membrane, which is convenient for the installation of the filter membrane.
[0015] Furthermore, the structure for separating red blood cells includes a pipeline and a third chamber, one end of the pipeline is located between the filter membrane and the cover sheet, the other end of the pipeline is provided with a sample outlet, the sample outlet is connected to the third chamber, and a normally closed microvalve is provided on the pipeline. In this way, by opening the normally closed microvalve, the sample flows into the third chamber after passing through the filter membrane, and the blood sample after separating the red blood cells is stored in the third chamber for subsequent detection. The normally closed microvalve is a phase-changing normally closed microvalve or a mechanical normally closed microvalve.
[0016] Furthermore, a sealing film for sealing the magnetic bead cavity is provided on the substrate, and the sealing film is a polymer film or a metal film.
[0017] A biochip has the above-mentioned structure for separating red blood cells.
[0018] A device for separating red blood cells comprises the biochip, a magnet for adsorbing magnetic beads, a control mechanism for controlling a normally closed microvalve, and a driving mechanism for driving a plunger, wherein the magnet corresponds to the position of the first chamber, the control mechanism corresponds to the position of the normally closed microvalve, and the driving mechanism corresponds to the position of the plunger.
[0019] An instrument for analyzing and testing using a biochip includes the above-mentioned device for separating red blood cells. The plasma sample obtained after the whole blood sample passes through the filter membrane is transported through a pipeline, and a normally closed microvalve is provided on the pipeline to control the plasma sample to participate in subsequent testing.
[0020] A method for separating red blood cells, using the above device, comprises the following steps:
[0021] S1. Add the whole blood sample into the magnetic bead chamber and mix well;
[0022] S2, adding the mixed whole blood sample into the first chamber through the whole blood sample adding port;
[0023] S3, adsorbing the magnetic beads in the magnetic bead chamber on the side away from the filter membrane, and during the magnetic adsorption process, opening the normally closed microvalve to connect the second chamber with the sample outlet;
[0024] S4. Drive the plunger to slowly press down, so that the whole blood sample passes through the filter membrane in turn and is added to the third chamber to complete the filtration of the whole blood.
[0025] Furthermore, the time for adsorbing the magnetic beads in step S3 is 10 seconds to 60 seconds.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] (1) The area used by the filter membrane is reduced. To filter the same volume of whole blood sample, the area used by the filter membrane is one twenty-fifth of the original area.
[0028] (2) Avoid hemolysis and ensure reliable results;
[0029] (3) Domestic membranes can be used to reduce costs;
[0030] (4) It has a wide range of applications and is suitable for projects with different specimen volumes;
[0031] (5) The chip structure is simple, the process is widely applicable, and the process is simple. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 It is a schematic diagram of the structure of separating red blood cells of the present invention with the cover sheet removed and the plunger decomposed from the substrate;
[0033] Figure 2 is along Figure 1 E-direction schematic diagram;
[0034] Figure 3 yes Figure 2 The enlarged schematic diagram at D in the middle;
[0035] Figure 4 It is a schematic diagram of the structure in which the filter membrane and the cover sheet of the structure for separating red blood cells of the present invention are decomposed from the substrate.
[0036] Explanation of the reference numerals: 1. whole blood sample injection port; 2. first chamber; 3. vent; 4. plunger; 5. substrate; 6. connecting hole; 7. second chamber; 8. normally closed microvalve; 9. sample outlet; 10. third chamber; 11. permanent magnet; 12. magnetic bead chamber; 13. sealing membrane; 14. cover sheet; 15. filter membrane. DETAILED DESCRIPTION
[0037] The present invention will be described in detail below in conjunction with the embodiments. It should be noted that the embodiments and features in the embodiments of the present invention can be combined with each other without conflict.
[0038] See also Figure 1-Figure 4 A structure for separating red blood cells includes a substrate 5, on which a columnar whole blood sample port 1 and a first chamber 2 are vertically arranged in sequence, the whole blood sample port 1 is connected to the first chamber 2, a plunger 4 is arranged in the first chamber 2, the plunger 4 and the first chamber 2 are interference fit, the plunger 4 has been assembled on the substrate 5 before leaving the factory, the plunger 4 is made of rubber material, and a vent hole 3 is designed on the long side of the circumference of the first chamber 2, the vent hole 3 is designed from top to bottom, and the depth is 2mm deeper than the height of the plunger 4. The substrate 5 is made of a polymer material, preferably integrally injection molded.
[0039] A magnetic bead chamber 12 is provided on the left side of the first chamber 2, and the centers of the cross sections of the whole blood sample addition port 1, the first chamber 2, and the magnetic bead chamber 12 are on the same straight line. A plurality of magnetic beads are placed in the magnetic bead chamber 12, and red blood cell antibodies are bound to the magnetic beads. The particle size of the magnetic beads is preferably 0.1-1um, and red blood cell antibodies are coupled to the magnetic beads.
[0040] The substrate 5 has a C surface and an A surface and a B surface which are oppositely arranged at two ends of the C surface. A sealing film 13 for sealing the magnetic bead cavity 12 is provided on the C surface of the substrate 5, and the sealing film 13 is preferably an aluminum foil film.
[0041] like Figure 4As shown, an opening is provided at one end of the second chamber 7 facing the B surface, a boss is provided on the inner wall of the opening, the filter membrane 15 is fixedly connected to the second chamber 7 via the boss, and the filter membrane 15 is bonded to the second chamber 7; a cover sheet 14 is provided on the B surface of the substrate, and the second chamber 7 is covered by the cover sheet 14 to form a sealed chamber.
[0042] The second chamber 7 is connected to the bottom of the first chamber 2 through a connecting hole 6, and the diameter of the connecting hole 6 is 0.3-1 mm. The function of the connecting hole 6 is to prevent the whole blood from entering the second chamber 7 when the whole blood sample is added to the first chamber 2, so as to ensure that the red blood cells will not be adsorbed on the filter membrane 15. Without this design, when the whole blood sample is added, the red blood cells will be adsorbed on the filter membrane 15 and cannot be sucked away by the magnet, causing hemolysis during filtration.
[0043] The second chamber 7 is connected to the third chamber 10 through a pipeline. The third chamber 10 is located below the second chamber 7. The inlet of the pipeline is located between the filter membrane 15 and the cover sheet 14. There is a gap between the filter membrane 15 and the cover sheet 14 to ensure that the blood sample flows into the pipeline after passing through the filter membrane 15. The other end of the pipeline is connected to the third chamber 10 through the sample outlet 9. A normally closed microvalve 8 is provided in the pipeline. The normally closed microvalve 8 is located near the sample outlet 9 of the pipeline. The normally closed microvalve 8 is a phase-changing normally closed microvalve or a mechanical normally closed microvalve. By opening the normally closed microvalve 8, the blood sample passing through the filter membrane 15 drips from the sample outlet 9 into the third chamber 10.
[0044] A biochip has the structure for separating red blood cells.
[0045] A device for separating red blood cells comprises the biochip, a magnet 11 for adsorbing magnetic beads, a control mechanism for opening a normally closed microvalve 8, and a driving mechanism for driving a plunger 4 to move downward along a first chamber; the biochip is placed in the device, the magnet 11 is arranged on the outer side of the A surface of a substrate 5, the magnet 11 corresponds to the position of the first chamber, the control mechanism corresponds to the position of the normally closed microvalve 8, and the driving mechanism corresponds to the position of the plunger 4.
[0046] An instrument for analyzing and testing a biochip includes the device for separating red blood cells. The plasma sample obtained after the whole blood sample passes through the filter membrane is transported through a pipeline, and a normally closed microvalve is arranged on the pipeline to control the plasma sample to participate in subsequent testing.
[0047] A method for separating red blood cells, using the above-mentioned instrument, comprises the following steps:
[0048] S1. After getting the biochip, the medical staff pierces the sealing film 13 with a pipette, adds the whole blood sample into the magnetic bead chamber 12, and puts the biochip into the detection instrument for mixing, so that the red blood cells and magnetic beads are combined;
[0049] S2, the instrument adds the mixed whole blood into the first chamber 2 through the whole blood adding port 1;
[0050] S3, the instrument pushes the biochip to the magnetic attraction position, and the permanent magnet 11 adsorbs the magnetic beads on the side away from the filter membrane 15. The magnetic attraction time is 30 seconds to ensure that the red blood cells in the whole blood sample are adsorbed on the magnetic beads and attracted by the magnet 11. During the magnetic attraction process, the normally closed microvalve 8 is opened to connect the second chamber 7 with the sample outlet 9;
[0051] S4, driving the plunger 4 to slowly press down, so that the plasma in the whole blood sample is sequentially passed through the connecting hole 6, the filter membrane 15, the normally closed microvalve 8, and the sample outlet 9 and dripped into the third chamber 10, thereby completing the filtration of the whole blood sample.
[0052] The contents explained in the above embodiments should be understood as these embodiments are only used to more clearly illustrate the present invention, and are not used to limit the scope of the present invention. After reading the present invention, various equivalent forms of modifications to the present invention by those skilled in the art all fall within the scope defined by the claims attached to this application.
Claims
1. A structure for separating red blood cells, comprising a substrate (5), wherein the substrate (5) is provided with a whole blood sample injection port (1) and a first chamber (2), wherein the whole blood sample injection port (1) is connected to the first chamber (2), and a plunger (4) is provided in the first chamber (2), characterized in that: The invention also comprises a magnetic bead chamber (12) and a second chamber (7), wherein a plurality of magnetic beads are arranged in the magnetic bead chamber (12), and antibodies for adsorbing red blood cells are arranged on the magnetic beads. The bottom of the first chamber (2) is connected to the second chamber (7) through a connecting hole (6), and a filter membrane (15) is arranged in the second chamber (7).
2. The structure for separating red blood cells according to claim 1, characterized in that: The hole diameter of the connecting hole (6) is 0.3-1 mm.
3. The structure for separating red blood cells according to claim 1, characterized in that: The particle size of the magnetic beads is 0.1-5 μm.
4. The structure for separating red blood cells according to claim 1, characterized in that: The substrate (5) is provided with an A surface and a B surface opposite to each other; a boss is provided at one end of the second chamber (7) facing the B surface, and the filter membrane (15) is connected to the second chamber (7) via the boss; a cover sheet (14) is provided on the B surface of the substrate (5), and the second chamber (7) and the cover sheet (14) are covered to form a sealed chamber.
5. The structure for separating red blood cells according to claim 4, characterized in that: It comprises a pipeline and a third chamber (10), wherein the inlet end of the pipeline is located between a filter membrane (15) and a cover sheet (14), and the outlet end of the pipeline is connected to the third chamber (10) through a sample outlet (9), and a normally closed microvalve (8) is provided on the pipeline.
6. The structure for separating red blood cells according to claim 1, characterized in that: A sealing film (13) for sealing the magnetic bead cavity (12) is provided on the substrate (5).
7. A biochip, characterized in that: It has the structure for separating red blood cells according to any one of claims 1 to 6.
8. A device for separating red blood cells, characterized in that: It comprises the biochip as claimed in claim 7, a magnet (11) for adsorbing magnetic beads, a control mechanism for opening a normally closed microvalve (8), and a driving mechanism for driving a plunger (4), wherein the magnet (11) corresponds to the position of the first chamber (2), the control mechanism corresponds to the position of the normally closed microvalve (8), and the driving mechanism corresponds to the position of the plunger (4).
9. A method for separating red blood cells, characterized in that: Using the device of claim 8 to separate red blood cells comprises the following steps: S1, adding the whole blood sample into the magnetic bead chamber (12) and mixing; S2, adding the mixed whole blood sample into the first chamber (2) through the whole blood sample adding port (1); S3, adsorbing the magnetic beads in the first chamber (2) on the side facing away from the filter membrane (15), and during the magnetic adsorption process, opening the normally closed microvalve (8) to connect the second chamber (7) with the sample outlet (9); S4, driving the plunger (4) to slowly press downward, so that the whole blood sample passes through the filter membrane (15) and is added into the third chamber (10), thereby completing the filtering of the whole blood sample.
10. The method for separating red blood cells according to claim 9, characterized in that: The time for adsorbing the magnetic beads in step S3 is 10 seconds to 60 seconds.
Citation Information
Patent Citations
Method for rapidly separating supernatant from human whole blood or suspended red blood cells by utilizing lyophilized preparation
CN101445793A
Method for separating red corpuscle from whole blood
CN101469323A
Kit for separating red blood cells from whole blood and method for separating red blood cells from whole blood
CN111308070A
Immunomagnetic bead for separating red blood cells, and preparation method and application of immunomagnetic bead
CN111662869A
Immunomagnetic bead freeze-dried microspheres for separating red blood cells, preparation method and application of immunomagnetic bead freeze-dried microspheres and blood treatment device
CN117625529A
